Jennifer A Ligibel

Summary

Affiliation: Massachusetts General Hospital
Country: USA

Publications

  1. ncbi request reprint Obesity and breast cancer
    Jennifer Ligibel
    Department of Adult Oncology, Dana Farber Cancer Institute, Boston, Massachusetts 02215, USA
    Oncology (Williston Park) 25:994-1000. 2011
  2. doi request reprint American society of clinical oncology position statement on obesity and cancer
    Jennifer A Ligibel
    Jennifer A Ligibel, Dana Farber Cancer Institute, Boston, MA Catherine M Alfano, National Cancer Institute, Bethesda, MD Kerry S Courneya, University of Alberta, Edmonton, Alberta, Canada Wendy Demark Wahnefried, University of Alabama at Birmingham, Birmingham, AL Robert A Burger, University of Pennsylvania, Philadelphia, PA Rowan T Chlebowski, Harbor University of California Los Angeles Medical Center, Torrance, CA Carol J Fabian, University of Kansas Medical Center, Westwood, KS Ayca Gucalp, Lee W Jones, and Clifford A Hudis, Memorial Sloan Kettering Cancer Center Dawn L Hershman, Columbia University Medical Center, New York, NY Melissa M Hudson and Kirsten K Ness, St Jude Children s Research Hospital, Memphis, TN Madhuri Kakarala, Van Andel Institute, Grand Rapids, MI and Janette K Merrill and Dana S Wollins, American Society of Clinical Oncology, Alexandria, VA
    J Clin Oncol 32:3568-74. 2014
  3. doi request reprint Lifestyle factors in cancer survivorship
    Jennifer Ligibel
    Dana Farber Cancer Institute, Boston, MA 02215, USA
    J Clin Oncol 30:3697-704. 2012
  4. pmc Patterns of bone density evaluation in a community population treated with aromatase inhibitors
    Jennifer A Ligibel
    Dana Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215, USA
    Breast Cancer Res Treat 134:1305-13. 2012
  5. pmc Impact of a telephone-based physical activity intervention upon exercise behaviors and fitness in cancer survivors enrolled in a cooperative group setting
    Jennifer A Ligibel
    Dana Farber Cancer Institute, 450 Brookline Ave Boston, Boston, MA 02215, USA
    Breast Cancer Res Treat 132:205-13. 2012
  6. ncbi request reprint Role of adjuvant and posttreatment exercise programs in breast health
    Jennifer A Ligibel
    Dana Farber Cancer Institute and Harvard Medical School, Boston, MA 02115, USA
    J Natl Compr Canc Netw 9:251-6. 2011
  7. doi request reprint Physical and psychological outcomes among women in a telephone-based exercise intervention during adjuvant therapy for early stage breast cancer
    Jennifer A Ligibel
    Dana Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA
    J Womens Health (Larchmt) 19:1553-9. 2010
  8. doi request reprint Impact of a mixed strength and endurance exercise intervention on levels of adiponectin, high molecular weight adiponectin and leptin in breast cancer survivors
    Jennifer A Ligibel
    Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, 44 Binney Street, Boston, MA 02115, USA
    Cancer Causes Control 20:1523-8. 2009
  9. pmc Aromatase inhibitors as adjuvant therapy for postmenopausal women: a therapeutic advance but many unresolved questions
    Jennifer A Ligibel
    Harvard Medical School, Dana Farber Cancer Institute and Brigham and Women s Hospital, Boston, Massachusetts, USA
    Breast Cancer Res 7:255-7. 2005
  10. doi request reprint Impact of a mixed strength and endurance exercise intervention on insulin levels in breast cancer survivors
    Jennifer A Ligibel
    Dana Farber Cancer Institute, Brigham and Women s Hospital, Harvard Medical School, Channing Laboratory, Boston, MA, USA
    J Clin Oncol 26:907-12. 2008

Detail Information

Publications22

  1. ncbi request reprint Obesity and breast cancer
    Jennifer Ligibel
    Department of Adult Oncology, Dana Farber Cancer Institute, Boston, Massachusetts 02215, USA
    Oncology (Williston Park) 25:994-1000. 2011
    ....
  2. doi request reprint American society of clinical oncology position statement on obesity and cancer
    Jennifer A Ligibel
    Jennifer A Ligibel, Dana Farber Cancer Institute, Boston, MA Catherine M Alfano, National Cancer Institute, Bethesda, MD Kerry S Courneya, University of Alberta, Edmonton, Alberta, Canada Wendy Demark Wahnefried, University of Alabama at Birmingham, Birmingham, AL Robert A Burger, University of Pennsylvania, Philadelphia, PA Rowan T Chlebowski, Harbor University of California Los Angeles Medical Center, Torrance, CA Carol J Fabian, University of Kansas Medical Center, Westwood, KS Ayca Gucalp, Lee W Jones, and Clifford A Hudis, Memorial Sloan Kettering Cancer Center Dawn L Hershman, Columbia University Medical Center, New York, NY Melissa M Hudson and Kirsten K Ness, St Jude Children s Research Hospital, Memphis, TN Madhuri Kakarala, Van Andel Institute, Grand Rapids, MI and Janette K Merrill and Dana S Wollins, American Society of Clinical Oncology, Alexandria, VA
    J Clin Oncol 32:3568-74. 2014
    ....
  3. doi request reprint Lifestyle factors in cancer survivorship
    Jennifer Ligibel
    Dana Farber Cancer Institute, Boston, MA 02215, USA
    J Clin Oncol 30:3697-704. 2012
    ..This article reviews the evidence that links lifestyle factors to cancer outcomes, provides clinical recommendations for cancer survivors, and describes future directions for lifestyle research in cancer survivors...
  4. pmc Patterns of bone density evaluation in a community population treated with aromatase inhibitors
    Jennifer A Ligibel
    Dana Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215, USA
    Breast Cancer Res Treat 134:1305-13. 2012
    ..Attention is needed to insure that unnecessary fractures are avoided in breast cancer patients taking AIs...
  5. pmc Impact of a telephone-based physical activity intervention upon exercise behaviors and fitness in cancer survivors enrolled in a cooperative group setting
    Jennifer A Ligibel
    Dana Farber Cancer Institute, 450 Brookline Ave Boston, Boston, MA 02215, USA
    Breast Cancer Res Treat 132:205-13. 2012
    ..Lifestyle intervention research is feasible in a cooperative group setting...
  6. ncbi request reprint Role of adjuvant and posttreatment exercise programs in breast health
    Jennifer A Ligibel
    Dana Farber Cancer Institute and Harvard Medical School, Boston, MA 02115, USA
    J Natl Compr Canc Netw 9:251-6. 2011
    ..This article reviews the growing evidence that exercise could be an important part of breast cancer survivorship, and describes current exercise guidelines for breast cancer survivors...
  7. doi request reprint Physical and psychological outcomes among women in a telephone-based exercise intervention during adjuvant therapy for early stage breast cancer
    Jennifer A Ligibel
    Dana Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA
    J Womens Health (Larchmt) 19:1553-9. 2010
    ..Studies have suggested that decreases in physical activity during treatment may contribute to weight gain in breast cancer patients...
  8. doi request reprint Impact of a mixed strength and endurance exercise intervention on levels of adiponectin, high molecular weight adiponectin and leptin in breast cancer survivors
    Jennifer A Ligibel
    Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, 44 Binney Street, Boston, MA 02115, USA
    Cancer Causes Control 20:1523-8. 2009
    ..This study examines the impact of exercise upon levels of adiponectin, high molecular weight adiponectin (HMWA), and leptin in breast cancer survivors...
  9. pmc Aromatase inhibitors as adjuvant therapy for postmenopausal women: a therapeutic advance but many unresolved questions
    Jennifer A Ligibel
    Harvard Medical School, Dana Farber Cancer Institute and Brigham and Women s Hospital, Boston, Massachusetts, USA
    Breast Cancer Res 7:255-7. 2005
    ..Ongoing trials will compare these approaches and guide the use of these agents in the years to come...
  10. doi request reprint Impact of a mixed strength and endurance exercise intervention on insulin levels in breast cancer survivors
    Jennifer A Ligibel
    Dana Farber Cancer Institute, Brigham and Women s Hospital, Harvard Medical School, Channing Laboratory, Boston, MA, USA
    J Clin Oncol 26:907-12. 2008
    ..We sought to analyze whether exercise lowered insulin concentrations in breast cancer survivors...
  11. doi request reprint Physical activity behaviors in women with newly diagnosed ductal carcinoma-in-situ
    Jennifer A Ligibel
    Dana Farber Cancer Institute, 44 Binney Street, Boston, MA 02115, USA
    Ann Surg Oncol 16:106-12. 2009
    ..Women who underwent mastectomy, as well as women who were more anxious, were more likely to decrease their level of physical activity. Women with DCIS might benefit from targeted interventions to increase physical activity...
  12. doi request reprint Risk of myocardial infarction, stroke, and fracture in a cohort of community-based breast cancer patients
    Jennifer A Ligibel
    Department of Adult Oncology, Dana Farber Cancer Institute, Boston, MA, USA
    Breast Cancer Res Treat 131:589-97. 2012
    ..The side effect profile of AIs in this community-based population was similar to that seen in clinical trials. These findings provide reassurance that AIs appear to be associated with few serious side effects...
  13. pmc The role of obesity in cancer survival and recurrence
    Wendy Demark-Wahnefried
    Department of Nutrition Sciences, University of Alabama at Birmingham, Alabama 35294, USA
    Cancer Epidemiol Biomarkers Prev 21:1244-59. 2012
    ....
  14. doi request reprint A phase I study of lapatinib with whole brain radiotherapy in patients with Human Epidermal Growth Factor Receptor 2 (HER2)-positive breast cancer brain metastases
    Nancy U Lin
    Harvard Medical School, Dana Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA
    Breast Cancer Res Treat 142:405-14. 2013
    ..Given the high ORR, concurrent lapatinib-WBRT could still be considered for future study with careful safety monitoring. ..
  15. pmc A phase II study of sagopilone (ZK 219477; ZK-EPO) in patients with breast cancer and brain metastases
    Rachel A Freedman
    Department of Medical Oncology, Dana Farber Cancer Institute, 44 Binney Street, Harvard Medical School, Boston, MA 02115, USA
    Clin Breast Cancer 11:376-83. 2011
    ..We observed modest activity with a central nervous system objective response rate of 13.3%; however, median PFS was disappointing. Further studies should focus on other agents to treat this challenging clinical problem...
  16. ncbi request reprint Clinical differences among the aromatase inhibitors
    Jennifer A Ligibel
    Harvard Medical School, Women s Hospital, Boston, Massachusetts 02115, USA
    Clin Cancer Res 9:473S-9S. 2003
    ..This article explores the efficacy and tolerability of the aromatase inhibitors in both the metastatic and the adjuvant settings...
  17. pmc Impact of diabetes on oncologic outcome of colorectal cancer patients: colon vs. rectal cancer
    Justin Y Jeon
    Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
    PLoS ONE 8:e55196. 2013
    ..To evaluate the impact of diabetes on outcomes in colorectal cancer patients and to examine whether this association varies by the location of tumor (colon vs. rectum)...
  18. ncbi request reprint New NCCN guidelines for survivorship care
    Jennifer A Ligibel
    Department of Medicine, Harvard Medical School, and Adult Oncology, Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA jligibel partners org
    J Natl Compr Canc Netw 11:640-4. 2013
    ..They also discuss implementing new recommendations on survivorship assessment in the clinic...
  19. pmc Obesity at diagnosis is associated with inferior outcomes in hormone receptor-positive operable breast cancer
    Joseph A Sparano
    Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York, USA
    Cancer 118:5937-46. 2012
    ..Obesity has been associated with inferior outcomes in operable breast cancer, but the relation between body mass index (BMI) and outcomes by breast cancer subtype has not been previously evaluated...
  20. doi request reprint Mucinous breast carcinoma: a large contemporary series
    Christina R Barkley
    Department of Surgery, Brigham and Women s Hospital, Boston, MA, USA
    Am J Surg 196:549-51. 2008
    ..Mucinous breast cancer is typically associated with a favorable prognosis. This study aimed to assess recent trends and prognostic features in the treatment of mucinous breast carcinoma...
  21. pmc Screening, assessment, and management of fatigue in adult survivors of cancer: an American Society of Clinical oncology clinical practice guideline adaptation
    Julienne E Bower
    Julienne E Bower and Patricia A Ganz, University of California at Los Angeles, Los Angeles, CA Kate Bak and Christina Lacchetti, American Society of Clinical Oncology, Alexandria, VA Ann Berger, National Institutes of Health Clinical Center, Bethesda, MD William Breitbart, Memorial Sloan Kettering Cancer Center, New York, NY Carmelita P Escalante, University of Texas MD Anderson Cancer Center, Houston, TX Hester Hill Schnipper, Beth Israel Deaconess Medical Center Jennifer A Ligibel, Dana Farber Cancer Institute William F Pirl, Massachusetts General Hospital, Boston, MA Gary H Lyman, Fred Hutchinson Cancer Research Center and the University of Washington, Seattle, WA Mohammed S Ogaily, Oakwood Center for Hematology and Oncology Downriver, Brownstown, MI and Paul B Jacobsen, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL
    J Clin Oncol 32:1840-50. 2014
    ..This guideline presents screening, assessment, and treatment approaches for the management of adult cancer survivors who are experiencing symptoms of fatigue after completion of primary treatment...
  22. ncbi request reprint Trastuzumab/chemotherapy combinations in metastatic breast cancer
    Jennifer A Ligibel
    Harvard Medical School, Boston, MA 02115, USA
    Semin Oncol 29:38-43. 2002
    ....